➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Colorcon
Express Scripts
Medtronic
Boehringer Ingelheim

Last Updated: September 26, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR FEXINIDAZOLE

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Fexinidazole

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00982904 ↗ Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the Fexinidazole Completed Sanofi Phase 1 2009-09-01 This study is aimed at assessing the tolerability and pharmacokinetic parameters of the fexinidazole in healthy volunteers. In animal models of both acute and chronic experimental Trypanosomiasis infections, fexinidazole shows highly promising efficacy.
NCT00982904 ↗ Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the Fexinidazole Completed Drugs for Neglected Diseases Phase 1 2009-09-01 This study is aimed at assessing the tolerability and pharmacokinetic parameters of the fexinidazole in healthy volunteers. In animal models of both acute and chronic experimental Trypanosomiasis infections, fexinidazole shows highly promising efficacy.
NCT01340157 ↗ Fexinidazole (1200mg) Bioavailability Under Different Food Intake Conditions Completed Sanofi Phase 1 2011-02-01 The present study is designed to assess the impact of concomitant food intake on the relative bioavailability of a single oral fexinidazole tablet administration.
NCT01340157 ↗ Fexinidazole (1200mg) Bioavailability Under Different Food Intake Conditions Completed Drugs for Neglected Diseases Phase 1 2011-02-01 The present study is designed to assess the impact of concomitant food intake on the relative bioavailability of a single oral fexinidazole tablet administration.
NCT01483170 ↗ Multiple Dose Study to Evaluate Security, Tolerance and Pharmacokinetic of Fexinidazole (Drug Candidate for Human African Trypanosomiasis) Administered With a Loading Dose and With Food Terminated Drugs for Neglected Diseases Phase 1 2011-09-01 This trial will study the tolerability and pharmacokinetic of fexinidazole using two different dosage regimen of repeated administrations. The drug is administered to human healthy volunteers of sub-saharan origin together with food, once a day during 10 days, with a loading dose during 4 days.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Fexinidazole

Condition Name

Condition Name for Fexinidazole
Intervention Trials
Human African Trypanosomiasis (HAT) 3
Trypanosomiasis, African 3
Sleeping Sickness 2
Trypanosoma Brucei Rhodesiense; Infection 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Fexinidazole
Intervention Trials
Trypanosomiasis 9
Trypanosomiasis, African 8
Chagas Disease 2
Leishmaniasis, Visceral 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Fexinidazole

Trials by Country

Trials by Country for Fexinidazole
Location Trials
Congo 6
France 4
Congo, The Democratic Republic of the 3
Bolivia 1
Central African Republic 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Fexinidazole

Clinical Trial Phase

Clinical Trial Phase for Fexinidazole
Clinical Trial Phase Trials
Phase 3 1
Phase 2/Phase 3 4
Phase 2 3
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Fexinidazole
Clinical Trial Phase Trials
Recruiting 3
Active, not recruiting 3
Completed 3
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Fexinidazole

Sponsor Name

Sponsor Name for Fexinidazole
Sponsor Trials
Drugs for Neglected Diseases 12
Sanofi 3
European and Developing Countries Clinical Trials Partnership (EDCTP) 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Fexinidazole
Sponsor Trials
Other 13
Industry 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
Medtronic
AstraZeneca
McKinsey
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.